clinical value of motion synchronization for lung sbrt · 2019. 9. 16. · • standard motion...
TRANSCRIPT
![Page 1: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/1.jpg)
Jonathan W. Lischalk, M.D.Department of Radiation MedicineGeorgetown University Hospital
Clinical Value Of Motion Synchronization For Lung SBRT
![Page 2: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/2.jpg)
Disclaimer & Disclosure
• The views expressed in this presentation are those of the presenter and do not necessarily reflect the views or policies of Accuray Incorporated or its subsidiaries. No official endorsement by Accuray Incorporated or any of its subsidiaries of any vendor, products or services contained in this presentation is intended or should be inferred
• An honorarium is provided by Accuray Incorporated for this presentation
![Page 3: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/3.jpg)
Outline• Thoracic tumor motion and motion
management strategies• Is pre-treatment 4D-CT scan enough?• Tumor motion synchronization • Georgetown CyberKnife® thoracic experience
– Early stage non-small cell lung cancer (ES-NSCLC) long-term results
– Central / Ultra-central thoracic treatment– Thoracic re-irradiation
![Page 4: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/4.jpg)
Epidemiology
American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.
![Page 5: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/5.jpg)
Epidemiology
American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.
![Page 6: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/6.jpg)
SBRT as Standard of Care
Expanding literature also supports the use of SBRT in the high-risk medically operable and even medically operable patient population
![Page 7: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/7.jpg)
Thoracic Tumor Motion
• Respiratory motion during SBRT increases positional uncertainty leading to:– Underdose of the tumor– Overdose of adjacent organs at risk (OAR)
• Respiratory motion is traditionally assessed with pretreatment 4D-CT scan
![Page 8: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/8.jpg)
Thoracic Motion Depends on Location
Sonke JJ et al., IJROBP, 2008 v:70 i:2 ; p:590 -598, *Guckenberger M et al., Acta Oncol, 2006 v:45 i:7; p:897 -906. Worm ES et al., Acta Oncol, 2010 v:49 i:7; p:1177 -1183 **Yu H et al., Radiotherapy and Oncology, 2012;104(1):33-8.
Thoracic Motion depends on stage, location and BMI*,**
![Page 9: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/9.jpg)
Motion Depends on Location and BMI
Guckenberger M et al., Acta Oncol, 2006 v:45 i:7; p:897-906Worm ES et al., Acta Oncol, 2010 v:49 i:7; p:1177-1183
![Page 10: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/10.jpg)
Thoracic Motion Depends on Stage
Yu HZ et al., Radiotherapy and Oncology, 2012;104(1):33 -8.
![Page 11: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/11.jpg)
Patient-specific Motion Analysis
Underberg RWM et al., IJROBP, 2004 v:60 i:4; p:1283-1290
![Page 12: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/12.jpg)
Motion Management
• Standard motion management strategies:– Motion encompassment (i.e. ITV)– Motion mitigation (e.g. abdominal compression)– Breath-hold technique (e.g. DIBH*, MIBH**, ABC***)– Respiratory gating – Tumor motion synchronization
* Deep Inspiration Breath Hold** Maximum Inspiration Breath Hold** Activated Breathing Control
![Page 13: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/13.jpg)
Motion Management Strategies
• Challenges of management strategies:– Motion encompassment: dependent on 4D -CT scan
accuracy, larger target volume (ITV)– Abdominal compression: patient discomfort, reproducibility– Breath-hold technique: active patient participation, trained
therapist, system dependency, patient discomfort – Respiratory gating: system integration, external surrogate
dependency – Tumor motion synchronization : fiducials are required if lung
optimized treatment is not used (LOT), optical surface tracking may not represent internal motion
![Page 14: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/14.jpg)
Outline• Thoracic tumor motion and motion management
strategies• Is pre -treatment 4D -CT scan enough?• Tumor motion synchronization • Georgetown CyberKnife® thoracic experience
– Early s tage non-small cell lung cancer (ES-NSCLC) long-term results
– Central / Ultra-central thoracic treatment– Thoracic re-irradiation
![Page 15: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/15.jpg)
Axis of Motion as Assessed by 4D-CT
Lischalk et al., PRO, 2016 v:6 i:3; p:176 -182
![Page 16: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/16.jpg)
4D-CT Does Not Capture Real-time Maximal Tumor Deviations
Lischalk et al., PRO, 2016 v:6 i:3; p:176 -182
![Page 17: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/17.jpg)
Fractional Undercoverage by 4D-CT
Lischalk et al., PRO, 2016 v:6 i:3; p:176 -182
![Page 18: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/18.jpg)
Outline• Thoracic tumor motion and motion management
strategies• Is pre-treatment 4D-CT scan enough?• Tumor motion synchronization• Georgetown CyberKnife® thoracic experience
– Early s tage non-small cell lung cancer (ES-NSCLC) long-term results
– Central / Ultra-central thoracic treatment– Thoracic re-irradiation
![Page 19: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/19.jpg)
Thoracic Tumor Motion
Photo Courtesy of Georgetown
![Page 20: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/20.jpg)
CyberKnife® Tumor Motion Synchronization
Image provided by Accuray
![Page 21: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/21.jpg)
CyberKnife® Tumor Motion Synchronization
Patient set-up time minimized by efficient respiratory modeling workflow
![Page 22: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/22.jpg)
Impact of Motion Synchronization
• Motion synchronization accuracy consequences– Precludes the necessity of ITV creation– Minimizes underdose of the tumor– Minimizes overdose of adjacent OARs
• Thoracic clinical optimization– Definitive ES-NSCLC– Ablative management of central thoracic tumors– Thoracic re-irradiation
![Page 23: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/23.jpg)
Fiducial Placement• Fiducial placement techniques:
– Percutaneous– Bronchoscopic
• Bronchoscopic placement allows for:– Lower risk of pneumothorax– Mediastinal staging– Fiducial placement
• Fiducials: – Gold seeds, platinum coils, gold seeds
with coils
Alternatively, lung optimized treatment (LOT) allows CyberKnife® to synchronize treatments to the majority of lung targets without the need of implanted fiducialsImage provided by Accuray
![Page 24: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/24.jpg)
CyberKnife® for ES-NSCLC
![Page 25: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/25.jpg)
Outline• Thoracic tumor motion and motion management
strategies• Is pre-treatment 4D-CT scan enough?• Tumor motion synchronization• Georgetown CyberKnife ® thoracic experience
– Early stage non -small cell lung cancer (ES -NSCLC) long -term results
– Central / Ultra-central thoracic treatment– Thoracic re-irradiation
![Page 26: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/26.jpg)
Georgetown ES-NSCLC Experience
• Multiple methods of SBRT delivery exist including fiducial-based tumor tracking, which allows for smaller treatment margins and avoidance of patient immobilization devices
• We explored the long-term clinical outcomes of this novel fiducial-based SBRT method from 2005 to 2015
![Page 27: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/27.jpg)
Patient Population
Lischalk et al., J Radiat Oncol, August 2016 v:5 i:4; p:379-387
Median age of 75, pulmonary dysfunction the most common cause of inoperability, and most
tumors ≤ 3 cm
![Page 28: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/28.jpg)
Treatment Characteristics
The most common dose fractionation schedule was 50 Gy in 5 fractions
Lischalk et al., J Radiat Oncol, August 2016 v:5 i:4; p:379-387
![Page 29: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/29.jpg)
Clinical Outcomes
5-year local control: 88% 5-year locoregional control: 72%
Lischalk et al., J Radiat Oncol, August 2016 v:5 i:4; p:379-387
![Page 30: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/30.jpg)
Clinical Outcomes
Locoregional control was improved with BED above 105 Gy
Motion synchronization achieves high target BED while minimizing treatment volume
Squamous histology correlated with worse local control
Lischalk et al., J Radiat Oncol, August 2016 v:5 i:4; p:379-387
![Page 31: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/31.jpg)
Post-CyberKnife® PFT Changes
PFT changes after CyberKnife were minimally affected
Lischalk et al., J Radiat Oncol, August 2016 v:5 i:4; p:379-387
![Page 32: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/32.jpg)
Outline• Thoracic tumor motion and motion management
strategies• Is pre-treatment 4D-CT scan enough?• Tumor motion synchronization• Georgetown CyberKnife ® thoracic experience
– Early s tage non-small cell lung cancer (ES-NSCLC) long-term results
– Central / Ultra -central thoracic treatment– Thoracic re-irradiation
![Page 33: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/33.jpg)
Georgetown Central Lung Tumors Experience
• Excessive toxicity historically noted in patients with “central” tumors– Particularly when treating with 3 fraction SBRT – Moderate hypofractionation schedules have been proposed
(60Gy/8)– RTOG 0813 demonstrated no grade 3+ acute and late toxicity
for those treated with 50Gy/5– No clear data regarding management of “ultracentral” lung
tumors• We explore the clinical outcomes C yberKnife®-based SBRT for
ultracentral metastatic tumors abutting or invading the mainstem bronchus
![Page 34: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/34.jpg)
High-risk Central Tumors
JW Lischalk et al., Radiation Oncology, 2016 v:11; p:28
SCC and ADA were the most common histologies treated
![Page 35: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/35.jpg)
High-risk Central Tumors
Median major bronchus Dmax 46.4 Gy
1-year local control and overall survival: 70% and 75%, respectively
JW Lischalk et al., Radiation Oncology, 2016 v:11; p:28
![Page 36: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/36.jpg)
High-risk Central Tumors
5-year complete response to CyberKnife®-SBRT for ultracentral pulmonary lesion on PET/CT
![Page 37: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/37.jpg)
High-Risk Central Tumors
Most commonly reported grade 2 or higher toxicity was atelectasis
JW Lischalk et al., Radiation Oncology, 2016 v:11; p:28
![Page 38: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/38.jpg)
High-Risk Central Tumors
Patients with pre-SBRT documented gross endobronchial involvement demonstrated significantly lower median overall survival (4.8 vs. 19.8 months, p = 0.029), and a trend in decreased local control (4.49 vs. 21.9 months, p = 0.085)
JW Lischalk et al., Radiation Oncology, 2016 v:11; p:28
![Page 39: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/39.jpg)
Thoracic Re-irradiation• Advanced RT modality options exist for thoracic
reirradiation, including:– Stereotactic body radiation therapy– Proton beam radiation therapy– Altered fractionation
• We explore the clinical outcomes C yberKnife®-based re-irradiation for ultracentral (i.e. abutting main pulmonary tree and esophagus) in-field pulmonary recurrences after definitive doses of conventionally fractionated radiotherapy
![Page 40: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/40.jpg)
Ultracentral Re-irradiation
Repka et al., Radiation Oncology, 2017 v:12 i:1; p:162
Most common histology was ADA, and most common re-irradiation
dose was 35Gy in 5 fractions
![Page 41: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/41.jpg)
Ultracentral Re-irradiation
Repka et al., Radiation Oncology, 2017 v:12 i:1; p:162
![Page 42: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/42.jpg)
Ultracentral Re-irradiation
1-year local control was 67% in those treated with SBRT doses ≥40 Gy
Repka et al., Radiation Oncology, 2017 v:12 i:1; p:162
![Page 43: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/43.jpg)
Ultracentral Re-irradiation
1-year overall survival was 78% in those treated with SBRT doses ≥40 Gy
Repka et al., Radiation Oncology, 2017 v:12 i:1; p:162
![Page 44: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/44.jpg)
Ultracentral Re-irradiation
The most common toxicities were pneumonitis and recurrent laryngeal nerve paralysis, both of which resolved prior to last follow-up. One patient
died suddenly 35 months after SBRT which was attributed to radiation toxicity (hemoptysis), although the cause of death was not formally proven.
Repka et al., Radiation Oncology, 2017 v:12 i:1; p:162
![Page 45: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/45.jpg)
Conclusions
• Definitive treatment of ES -NSCLC: Excellent long-term outcomes are
achieved with CyberKnife®-based SBRT and allow for optimal
intrafractional motion synchronization precluding the necessity of an
ITV
• Ultracentral pulmonary masses: Can be effectively treated with
CyberKnife® -based SBRT with durable local control, but close
attention should be paid to doses to the proximal bronchial tree
• Thoracic re -irradiation: CyberKnife® is a valuable option for patients
with in-field pulmonary locoregional recurrences after receiving
definitive doses of conventionally fractionated radiotherapy, and doses
≥40 Gy are associated with improved outcomes
![Page 46: Clinical value of motion synchronization for lung SBRT · 2019. 9. 16. · • Standard motion management strategies: – Motion encompassment (i.e. ITV) – Motion mitigation](https://reader036.vdocuments.site/reader036/viewer/2022071508/6129933792cc41683f36dea4/html5/thumbnails/46.jpg)